CAR-T cells engineered with doublecortin-like kinase 1(DCLK1)-scFv (CBT-511) blocked the growth of subcutaneous xenograft tumors derived from LoVo CRC cells [176]. This evidence concerns the gene DCLK1 and colorectal carcinoma.